Navigation Links
Law Office of Brodsky & Smith, LLC Announces Settlements of Yaz, and Yasmin Cases

BALA CYNWYD, Pa., Aug. 2, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against Bayer AG ("Bayer") (XETRA- BAYN.DE) and Barr Laboratories, Inc. ("Barr"") on behalf of individuals that suffered an adverse side effect while taking Yaz or Yasmin, and their generic version Ocella, such as blood clots, deep vein thrombosis, strokes, or a heart attacks.

Bayer has announced that it has reached agreements to settle cases with a total of 1,877 claimants that used these combinational oral contraceptives that contained both estrogen and progestins not found in other oral contraceptives. Bayer has also reported that there are 13,530 claimants remaining that they currently know of in the U.S. and that they expect both the number of claimants and settled cases to continue to grow. On April 10, 2012, the US Food and Drug Administration announced that Bayer's Yaz birth-control pill and similar medications may carry a higher risk of blood clots than other pills.  

If you or a family member have suffered a serious injury or a loved one died after taking Yaz, Yazmin, or Ocella and you wish to discuss the legal ramifications of these settlements or your right to obtain compensation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.  You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at, or by calling toll free 877-LEGAL-90.


SOURCE Brodsky & Smith, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. RxAlly Strengthens Leadership Team With New Chief Information Officer Mike Groh
2. Insmed Announces Planned Departure Of Chief Financial Officer
3. Quanterix Appoints Paul Chapman as President and Chief Executive Officer
4. Celladon Corporation Receives Patent from United States Patent and Trademark Office
5. Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologics Acquisition of Gen-Probe
6. HeartWare Names Peter F. McAree Chief Financial Officer
7. Merz, Inc. Announces Promotion of Katrina Church to Vice President, Chief Compliance Officer
8. KannaLife Sciences, Inc. Signs Exclusive License Agreement with National Institutes of Health Office of Technology Transfer (NIH-OTT)
9. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
10. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
11. Tara Dall, MD Joins Health Diagnostic Laboratory (HDL, Inc.) as Chief Medical Officer
Post Your Comments:
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)...  Consumer reviews on the independent review site Consumer Affairs ... company for hearing aids, ranking it higher than Miracle Ear ... ... For Hearing Aids ... online store that provides high performance, state-of-the-art, German-engineered hearing aids directly ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... ... 2017 , ... Health Literacy Innovations (HLI), creator of the ... the Cancer Patient Education Network (CPEN), an independent professional organization that shares best ... alliance. , As CPEN’s strategic partner, HLI will help support CPEN members ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Dining at the University of California Berkeley, and other leading institutions in announcing ... buying power of institutions to change the way animals are raised for food. ...
Breaking Medicine News(10 mins):